Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intraosseous versus intraarticular plasma rich in growth factors in knee osteoarthritis
2017-000623-27Phase 4Active
- Sponsor
- Fundación para la Investigación Biomédica del Hospital Universitario Príncipe de Asturias
- Start
- Jun 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in knee osteoarthritis (OA) and osteoarthritis (OA) comparing Intraosseous + intraarticular PRGF with Intraarticular PRGF + intraosseous placebo (2 arms). Primary endpoint: KOOS score at 6 months. Started Jun 2017; status: active.
02
Drugs
PRGF-Endoret
03
Conditions
knee osteoarthritis (OA)osteoarthritis (OA)
Beyond the preview
Go deeper on 2017-000623-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000623-27.